Center ·News report
An m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.
← 2026-10-23 archive
ARCHIVED · 2 LEFT · 1 CENTER · 1 RIGHT · Oct 23, 1:16 AM
Different Spin
An m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
Scientific American and The Washington Times describe the same event in different terms.
Archive
30-SECOND READ
What happenedA first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return.
What changedThe left frames it as "A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%". The right frames it as "A novel m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors return...".
ConfidenceHigh. 6+ sources across left, center, and right with comparable news formats.
Archive healthStable · 18 sources · all three buckets · comparable news format
WORDING GAP
73WORDING GAP
4 sources · 3 bias buckets · High confidence
Different Spin. The left frames it as "A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%". The right frames it as "A novel m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors return...".
SOURCE MAP TIMELINE
Oct 22, 10:23 PM: The Washington Times joined the source map.
Oct 22, 10:55 PM: Scientific American joined the source map.
Oct 22, 11:22 PM: WDSU New Orleans (Hearst) joined the source map.
Oct 22, 11:54 PM: Time joined the source map.
Now: Wording Gap is 73/99 and story health is stable · 18 sources · all three buckets · comparable news format.
ARCHIVED SOURCES
Open source
Center-left ·News report
Time1h ago
A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%
The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.
Center-left ·News report
Scientific American1h ago
Here’s what Moderna’s latest m RNA cancer vaccine data actually show
The Moderna-Merck m RNA cancer vaccine helps prevent cancer recurrence and death, the new results show
Center-right ·News report
The Washington Times2h ago
A novel m RNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Mode...